Invion (ASX:IVX) — Material Events
ASX:IVX · 8 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
Invion Lines Up Funding for 85% of Clinical Trial CostsHigh
Invion secures funding covering up to 85% of clinical trial costs
21 Oct 2026
·Funding Agreement
·Unexpected
·88
Invion Secures $2M Korean Grant, Expands Photosoft License, Raises $1.3MMedium
Invion secures $2M Korean grant, expands Photosoft license, raises $1.3M convertible notes
30 Jan 2026
·Quarterly Activity and Appendix 4C Cash Flow Report
·85
Invion Secures Exclusive Global License for Photosoft™ Across Multiple DiseasesMedium
Invion Secures Exclusive Global License for Photosoft™ Technology Across Multiple Indications
3 Dec 2025
·License Agreement Announcement
·85
Invion Expands Skin Cancer Trial to Basal Cell Carcinoma After Positive Safety and Efficacy SignalsMedium
Invion expands skin cancer trial to Basal Cell Carcinoma after positive safety and efficacy signals
21 Apr 2026
·Clinical Trial Update
·85
Invion Clinches FDA Orphan Drug Status, Raises $1.8M, Advances Cancer TrialsMedium
Invion secures FDA Orphan Drug Designation, raises $1.8M, advances cancer trials and animal health collaboration
31 Oct 2025
·Activity Report and Appendix 4C
·85
Invion and Hanlim Secure $2M Boost for Oesophageal Cancer Therapy TrialsMedium
Invion secures A$2M non-dilutive funding for oesophageal cancer preclinical program with Hanlim and South Korean government support
23 Dec 2025
·ASX Announcement
·80
Invion Secures $1.3M to Accelerate Cancer Trials with CEO Leading the ChargeMedium
Invion raises $1.3M via convertible notes to fund cancer clinical trials with CEO and major shareholder as cornerstone investors
30 Jan 2026
·Capital Raising
·75
Invion Expands Photosoft Platform to Target $16.7B Wet AMD MarketMedium
Invion partners with SANGMYUNG to advance Photosoft technology for wet AMD treatment
19 May 2026
·Collaboration Agreement
·75
No articles in this tier for the last 12 months.
Market Mentions
3
- appeared in market wrap coverage
These are market wrap articles where Invion (ASX:IVX) was mentioned. They reflect broader market coverage, not company-specific announcements.
Healthcare Wrap - Week 21 (18 May -> 22 May) 2026
23 May 2026
Healthcare Wrap - Week 17 (20 Apr -> 24 Apr) 2026
25 Apr 2026
Healthcare Wrap - Week 5 (26 Jan -> 30 Jan) 2026
31 Jan 2026